Holen Sie sich die Stockscreener-App
0.7399
5.44%
0.0382
Galmed Pharmaceuticals Ltd Aktie (GLMD) Neueste Nachrichten
Galmed Pharmaceuticals Ltd. and Ramot At Tel Aviv University Enter Research Collaboration Agreement - marketscreener.com
Galmed partners with Tel Aviv University on brain cancer therapy By Investing.com - Investing.com Australia
Galmed Pharmaceuticals Teams with Tel Aviv University on Aramchol for Metastatic Brain Cancer - TipRanks
Galmed (NASDAQ: GLMD) and Tel Aviv University test Aramchol for brain cancer - Stock Titan
GLMD SEC FilingsGalmed Pharmaceu 10-K, 10-Q, 8-K Forms - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Galmed stock soars on brain-penetrating Aramchol formulation - MSN
Galmed Stock Soars On Brain-Penetrating Aramchol FormulationGalmed Pharmaceuticals (NASDAQ:GLMD) - Benzinga
Galmed Unveils Brain-Penetrant Aramchol Formulation, Expanding Flagship Drug Into CNS Diseases - TipRanks
Galmed Pharmaceuticals Maps Future with Aramchol Strategy - timothysykes.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol - ChartMill
[EFFECT] Galmed Pharmaceuticals Ltd. SEC Filing - Stock Titan
Going concern doubts and funding limits in Galmed (NASDAQ: GLMD) 2025 20-F - Stock Titan
MEDIA ADVISORY – Minister LeBlanc, Secretary of State Long and Parliamentary Secretary Myles to highlight investments supporting the Canadian Armed Forces following achievement of the NATO 2% defence spending target - Weekly Voice
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025 - ChartMill
Galmed Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Ideas Watch: Is Galmed Pharmaceuticals Ltd stock a good dividend stock2026 Update & Entry and Exit Point Strategies - baoquankhu1.vn
Portfolio Update: Can Galmed Pharmaceuticals Ltd grow without dilution2026 Recap & Safe Entry Point Alerts - baoquankhu1.vn
GLMD Stock Price, Quote & Chart | GALMED PHARMACEUTICALS LTD (NASDAQ:GLMD) - ChartMill
Sectors Review: Can Galmed Pharmaceuticals Ltd deliver consistent dividendsMarket Rally & Low Risk Growth Stock Ideas - baoquankhu1.vn
Galmed (GLMD) director David Sidransky reports initial share and option holdings - Stock Titan
Galmed (GLMD) CFO details Ordinary Share, option and RSU holdings - Stock Titan
[Form 3] Galmed Pharmaceuticals Ltd. In... - Stock Titan
Galmed Pharmaceuticals (NASDAQ: GLMD) CAO reports shares, options and RSUs - stocktitan.net
Galmed Pharmaceuticals Ltd. (GLMD) CSO details option holdings - Stock Titan
Galmed (GLMD) director Amir Poshinski details shares, RSUs and options - Stock Titan
Galmed Pharmaceuticals (GLMD) director Nir Shmuel details initial share and RSU holdings - Stock Titan
Aug Chart Watch: Will Galmed Pharmaceuticals Ltd. stock maintain dividend yieldShort Setup & Advanced Swing Trade Entry Plans - Naître et grandir
Smart Money: Is Galmed Pharmaceuticals Ltd stock a good dividend stockMarket Growth Review & Reliable Price Breakout Signals - baoquankhu1.vn
Galmed Pharmaceuticals Shares Edge Higher Following CEO’s Positive Update - MSN
Galmed Pharmaceuticals Shareholders Approve Proposal at Special Meeting - The Globe and Mail
Galmed Pharmaceuticals (NASDAQ: GLMD) shareholders back proposal at March 5 special meeting - Stock Titan
Galmed Pharmaceuticals Adjourns Special Shareholder Meeting for Lack of Quorum - TipRanks
Galmed Pharmaceuticals (GLMD) adjourns shareholder meeting and resets date - Stock Titan
GLMD.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
GLMD Should I Buy - Intellectia AI
Buyout Rumor: Will Galmed Pharmaceuticals Ltd benefit from government policyWeekly Trend Report & Fast Momentum Entry Tips - baoquankhu1.vn
GLMD PE Ratio & Valuation, Is GLMD Overvalued - Intellectia AI
Can Galmed Pharmaceuticals Ltd. ride the EV waveWeekly Trend Recap & Daily Profit Focused Screening - mfd.ru
Why Galmed Pharmaceuticals Ltd. (GPH) stock is a must watch tickerTrade Ideas & Comprehensive Market Scan Reports - mfd.ru
Dip Buying: Why Galmed Pharmaceuticals Ltd. (GPH) stock is a must watch tickerTrade Risk Assessment & Stepwise Swing Trade Plans - mfd.ru
Can Galmed Pharmaceuticals Ltd. deliver consistent dividends2025 Price Targets & Long-Term Growth Portfolio Plans - mfd.ru
What’s the RSI of Galmed Pharmaceuticals Ltd. stockTreasury Yields & Community Consensus Picks - mfd.ru
Galmed Pharmaceuticals schedules special shareholder meeting for March 4 - Investing.com Nigeria
Galmed Pharmaceuticals Sets March 4 Vote on Reverse Stock Split to Address Nasdaq Listing Deficiency - TipRanks
Galmed Pharmaceuticals (NASDAQ: GLMD) seeks shareholder approval for broad reverse split range - Stock Titan
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Aug Summary: Will Galmed Pharmaceuticals Ltd benefit from government policyJuly 2025 Weekly Recap & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Galmed Pharmaceuticals Receives Nasdaq Minimum Bid Price Deficiency Notice - TipRanks
Galmed Pharmaceuticals receives Nasdaq minimum bid price notice - Investing.com
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification - PR Newswire
Nasdaq warns Galmed: lift share price above $1 or face delisting - Stock Titan
Published on: 2026-01-20 07:51:30 - bollywoodhelpline.com
Market Review: Can Home Bancorp Inc maintain its current growth rateQuarterly Portfolio Summary & Consistent Profit Alerts - baoquankhu1.vn
How volatile is Galmed Pharmaceuticals Ltd stockTrade Analysis Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
Price Action: What are IBKRs technical support levelsQuarterly Trade Report & Short-Term High Return Strategies - baoquankhu1.vn
Galmed Pharmaceuticals (NASDAQ:GLMD) Share Price Crosses Below 50-Day Moving Average – Should You Sell? - Defense World
Trade Recap: Is Galmed Pharmaceuticals Ltd stock a good dividend stock2025 Analyst Calls & Long-Term Growth Stock Strategies - baoquankhu1.vn
Chart Watch: Will Galmed Pharmaceuticals Ltd benefit from government policyWeekly Investment Report & Smart Investment Allocation Insights - baoquankhu1.vn
Stock Report: Is Galmed Pharmaceuticals Ltd in a long term uptrendJuly 2025 Market Mood & Daily Growth Stock Tips - baoquankhu1.vn
Galmed Pharmaceuticals Secures Shareholder Approval at Annual Meeting - MSN
Volume Report: How Galmed Pharmaceuticals Ltd GPH stock expands through international marketsPortfolio Value Report & Free Verified High Yield Trade Plans - Bộ Nội Vụ
Will Galmed Pharmaceuticals Ltd. stock outperform Dow Jones indexPortfolio Value Report & Verified Short-Term Plans - ulpravda.ru
What makes Galmed Pharmaceuticals Ltd. (GPH) stock appealing to growth investorsMarket Risk Analysis & Fast Exit and Entry Trade Guides - Улправда
What technical charts say about Galmed Pharmaceuticals Ltd. stockMarket Performance Summary & Stepwise Entry and Exit Trade Signals - ulpravda.ru
How Galmed Pharmaceuticals Ltd. stock reacts to job market data2025 Performance Recap & Low Drawdown Momentum Ideas - Улправда
0.73%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):